Overexpression of mRNA-decapping enzyme 1a predicts disease-specific survival in malignant melanoma

Melanoma Research
Yong TangWeikang Zhang

Abstract

Our previous study identified that rs11551405 A allele located at the 3' UTR of mRNA-decapping enzyme 1a (DCP1A) was associated with an increased risk for malignant melanoma (MM). The aim of this study was to investigate whether that association is manifested at the DCP1A expression and whether an altered DCP1A expression can predict disease-specific survival (DSS) of MM patients. The DCP1A expression in specimens of 56 cases of primary MM (23 cases at TNM stage I-II and 33 cases at TNM stage III-IV) and 43 cases of benign nevi (BN) was measured by quantitative RT-PCR (qRT-PCR), immunohistochemistry, and western blotting. The levels of DCP1A expression and the clinical characteristics of the patients were recorded and compared, along with the DSS within the 3 years of follow-up. The average relative mRNA level of DCP1A was significantly (P=0.002) higher in the MM tissues (0.159±0.007) than that shown in the BN tissues (0.122±0.009). The DCP1A immunohistochemistry scores of MM samples (5.55±2.56) were significantly (P<0.001) higher than those of the BN samples (3.58±3.66). Tissue protein levels of DCP1A in MM (0.378±0.021) were much (P<0.05) higher than those in BN tissues (0.265±0.017). Higher DCP1A expression was significantly...Continue Reading

References

Feb 24, 1997·The Journal of Cell Biology·V I BashkirovW D Heyer
Apr 7, 2004·The Journal of Cell Biology·Nicolas CougotBertrand Séraphin
Jun 7, 2005·Nature Cell Biology·Jidong LiuRoy Parker
Apr 4, 2007·Molecular and Cellular Biology·Ana EulalioElisa Izaurralde
Feb 27, 2009·Prion·Adva Aizer, Yaron Shav-Tal
May 7, 2009·Genetics·Montgomery Slatkin
May 23, 2009·Nature Reviews. Molecular Cell Biology·Paul Anderson, Nancy Kedersha
Jan 19, 2011·Journal of Cell Science·Stacy L Erickson, Jens Lykke-Andersen
May 20, 2011·Nature·Björn SchwanhäusserMatthias Selbach
Jan 10, 2013·PloS One·Adva AizerYaron Shav-Tal
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Sep 25, 2014·Expert Review of Anticancer Therapy·Alessia E RussoMassimo Libra
Sep 28, 2014·Cancer Research·Ken FujimuraRichard L Klemke
Dec 9, 2014·Biochimica Et Biophysica Acta·Paul AndersonPavel Ivanov
Jul 29, 2015·Human Genomics·Marco TrerotolaSaverio Alberti
Mar 15, 2016·Nature Reviews. Genetics·Andrew P FeinbergAnita Göndör
Aug 30, 2016·Medicinal Research Reviews·Antoine MilletRachid Benhida
Sep 1, 2016·International Journal of Cancer. Journal International Du Cancer·Weikang ZhangQingyi Wei

❮ Previous
Next ❯

Citations

May 31, 2019·Circulation Research·Paula Ortiz-SánchezEnrique Lara-Pezzi
Jun 13, 2019·Journal of Cellular Physiology·Chengmin ShiYujian Zeng
Jun 15, 2020·Clinical and Translational Medicine·Olga KelemenGyorgy Marko-Varga
Jan 5, 2022·Photodermatology, Photoimmunology & Photomedicine·Liang DingGyorgy Paragh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.